Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InSight Telepsychiatry is a U.S. behavioral health services company focused on delivering psychiatry and therapy through telemedicine. The company built a national telepsychiatry network serving hospitals, community mental health centers, clinics, and direct-to-consumer settings, with offerings spanning on-demand, scheduled, and at-home care. In 2018, the business was recapitalized by Harbour Point Capital, and in December 2019 it merged with Regroup Telehealth to form InSight + Regroup. In January 2021, the combined organization rebranded as Array Behavioral Care, under which the legacy InSight business continues as part of a larger virtual behavioral health platform. For a healthcare analyst, InSight is best understood as the legacy operating company behind what became one of the largest telepsychiatry providers in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InSight Telepsychiatry.